Skip to Content

Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms

Femtrace has been approved for the relief of the vasomotor symptoms of menopause. Approval was not granted for the secondary indication of vulvar-vaginal atrophy. The comapny expects to launch Femtrace in the first quarter of 2005.

Posted: August 2004

Femtrace (estradiol acetate) FDA Approval History